Cargando…

Deficits in plasma oestradiol measurement in studies and management of breast cancer

The determination of plasma oestradiol has numerous applications in epidemiology, reproductive medicine and breast cancer management. Commercially available analytical methods, which measure the hormone levels without prior purification, have been successfully developed for measuring oestradiol in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowsett, Mitch, Folkerd, Elizabeth
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064106/
https://www.ncbi.nlm.nih.gov/pubmed/15642174
http://dx.doi.org/10.1186/bcr960
_version_ 1782123291762229248
author Dowsett, Mitch
Folkerd, Elizabeth
author_facet Dowsett, Mitch
Folkerd, Elizabeth
author_sort Dowsett, Mitch
collection PubMed
description The determination of plasma oestradiol has numerous applications in epidemiology, reproductive medicine and breast cancer management. Commercially available analytical methods, which measure the hormone levels without prior purification, have been successfully developed for measuring oestradiol in premenopausal women. The application of these methodologies to the quantification of the very low levels of oestradiol in postmenopausal women is more problematic in terms of accuracy and interpretation. The importance of using appropriate methodology is discussed and illustrated with data demonstrating the disparity in the results obtained when low levels of oestradiol were quantified using direct and indirect methods.
format Text
id pubmed-1064106
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-10641062005-03-11 Deficits in plasma oestradiol measurement in studies and management of breast cancer Dowsett, Mitch Folkerd, Elizabeth Breast Cancer Res Commentary The determination of plasma oestradiol has numerous applications in epidemiology, reproductive medicine and breast cancer management. Commercially available analytical methods, which measure the hormone levels without prior purification, have been successfully developed for measuring oestradiol in premenopausal women. The application of these methodologies to the quantification of the very low levels of oestradiol in postmenopausal women is more problematic in terms of accuracy and interpretation. The importance of using appropriate methodology is discussed and illustrated with data demonstrating the disparity in the results obtained when low levels of oestradiol were quantified using direct and indirect methods. BioMed Central 2005 2004-10-28 /pmc/articles/PMC1064106/ /pubmed/15642174 http://dx.doi.org/10.1186/bcr960 Text en Copyright © 2004 BioMed Central Ltd
spellingShingle Commentary
Dowsett, Mitch
Folkerd, Elizabeth
Deficits in plasma oestradiol measurement in studies and management of breast cancer
title Deficits in plasma oestradiol measurement in studies and management of breast cancer
title_full Deficits in plasma oestradiol measurement in studies and management of breast cancer
title_fullStr Deficits in plasma oestradiol measurement in studies and management of breast cancer
title_full_unstemmed Deficits in plasma oestradiol measurement in studies and management of breast cancer
title_short Deficits in plasma oestradiol measurement in studies and management of breast cancer
title_sort deficits in plasma oestradiol measurement in studies and management of breast cancer
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064106/
https://www.ncbi.nlm.nih.gov/pubmed/15642174
http://dx.doi.org/10.1186/bcr960
work_keys_str_mv AT dowsettmitch deficitsinplasmaoestradiolmeasurementinstudiesandmanagementofbreastcancer
AT folkerdelizabeth deficitsinplasmaoestradiolmeasurementinstudiesandmanagementofbreastcancer